文献速递贫血与红细胞疾病

镰状细胞病的探索性根治性基因治疗策略

Investigational curative gene therapy approaches to sickle cell disease.
PubMed 文献 · Blood Adv · 2021-01-01

本文综述镰状细胞病(SCD)的基因治疗策略,包括用病毒载体表达修饰珠蛋白基因或干扰RNA促进胎儿血红蛋白表达,以及多种基因编辑方法诱导胎儿血红蛋白或修正镰状突变,并讨论其临床研究进展。

要点

  • SCD目前唯一根治手段为异基因造血干细胞移植,但少数患者有合适供者。
  • 自体造血干细胞联合基因修饰是当前临床研究中的替代策略。
  • 策略包括病毒载体表达修饰珠蛋白或干扰RNA,以及基因编辑诱导胎儿血红蛋白或修正突变。

核心结论

  • 基因治疗是SCD根治性治疗的探索方向,多种策略正在临床研究中。

研究设计与样本

  • 本文为音频综述,讨论SCD基因治疗的多种策略及当前进展。

主要发现

  • 临床研究中的策略包括用病毒载体表达修饰珠蛋白基因以防止镰状血红蛋白聚合,或表达干扰RNA利用生理开关将成人红细胞中的成人β-镰状血红蛋白转换为胎儿血红蛋白。
  • 还包括多种基因编辑方法,目标是诱导胎儿血红蛋白或修正/修饰实际的镰状突变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sickle cell disease (SCD) is an inherited blood condition resulting from abnormal hemoglobin production. It is one of the most common genetic diseases in the world. The clinical manifestations are variable and range from recurrent acute and debilitating painful crises to life-threatening pulmonary, cardiovascular, renal, and neurologic complications. The only curative treatment of SCD at this time is bone marrow transplantation (also called hematopoietic stem cell transplantation) using healthy blood stem cells from an unaffected brother or sister or from an unrelated donor if one can be identified who is a match in tissue typing. Unfortunately, only a minority of patients with sickle cell has such a donor available. The use of autologous hematopoietic stem cells and alternative types of genetic modifications is currently under study in clinical research trials for this disease. The approaches include the use of viral vectors to express globin genes that are modified to prevent sickle hemoglobin polymerization or to express interfering RNAs to "flip the switch" in adult red cells from adult β-sickle hemoglobin to fetal hemoglobin using a physiologic switch, and several gene editing approaches with the goal of inducing fetal hemoglobin or correcting/modifying the actual sickle mutation. In this audio review, we will discuss these different approaches and review the current progress of curative therapy for SCD using gene therapy.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Williams DA, Esrick E. Investigational curative gene therapy approaches to sickle cell disease. Blood Adv. 2021. PMID: 34905048. doi:10.1182/bloodadvances.2021005567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。